Such fluctuations alter the energy status of cancer cells and interfere with signaling pathways (AMPK, mTOR), transcription factors (hypoxia-inducible factor 1 alpha; HIF1α), and proteins (glucose transporter; GLUT) known to be associated with PGC-1α activity [11]. The gene discussed is PPARGC1A; the disease is cancer.